1-3 of 3
Chiaki Nakaseko
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nilotinib vs dasatinib in achieving MR 4.5 for de novo chronic myeloid leukemia: the randomized JALSG CML212 study

Clinical Trials & Observations
Itaru Matsumura, Shigeki Ohtake, Yoshiko Atsuta, Mio Kurata, Yosuke Minami, Naoto Takahashi, Chiaki Nakaseko, Noriyoshi Iriyama, Katsumichi Fujimaki, Kazuhiko Kakihana, Yoji Ogasawara, Takaaki Ono, Masaya Okada, Tetsuzo Tauchi, Toshihiro Miyamoto, Kazunori Ohnishi, Emiko Sakaida, Shin Fujisawa, Yukio Kobayashi, Norio Asou, Tomoki Naoe, Hitoshi Kiyoi, Yasushi Miyazaki
Journal: Blood Advances
Blood Adv (2024) 8 (20): 5237–5247.
https://doi.org/10.1182/bloodadvances.2024012655
Published: 2024
Includes: Supplemental data
Journal Articles

KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesis

Yusuke Isshiki, Yaeko Nakajima-Takagi, Motohiko Oshima, Kazumasa Aoyama, Mohamed Rizk, Shuhei Kurosawa, Atsunori Saraya, Takashi Kondo, Emiko Sakaida, Chiaki Nakaseko, Koutaro Yokote, Haruhiko Koseki, Atsushi Iwama
Journal: Blood Advances
Blood Adv (2019) 3 (17): 2537–2549.
https://doi.org/10.1182/bloodadvances.2018028522
Published: 2019
Includes: Supplemental data
Journal Articles

Randomized study of imatinib for chronic myeloid leukemia: comparing standard dose escalation with aggressive escalation

Clinical Trials & Observations
Koichi Miyamura, Kazunori Ohnishi, Shigeki Ohtake, Noriko Usui, Chiaki Nakaseko, Hiroyuki Fujita, Shin Fujisawa, Toru Sakura, Hirokazu Okumura, Noriyoshi Iriyama, Nobuhiko Emi, Katsumichi Fujimaki, Sumihisa Honda, Yasushi Miyazaki, Tomoki Naoe
Journal: Blood Advances
Blood Adv (2019) 3 (3): 312–319.
https://doi.org/10.1182/bloodadvances.2018025981
Published: 2019
Includes: Supplemental data